APA

Casneuf T., Axel A. E., King P., Alvarez J. D., Werbeck J. L., Verhulst T., Verstraeten K., Hall B. M. & Sasser A. K. (20160219). Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. : Breast cancer (Dove Medical Press).

Chicago

Casneuf Tineke, Axel Amy E, King Peter, Alvarez John D, Werbeck Jillian L, Verhulst Tinne, Verstraeten Karin, Hall Brett M and Sasser A Kate. 20160219. Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. : Breast cancer (Dove Medical Press).

Harvard

Casneuf T., Axel A. E., King P., Alvarez J. D., Werbeck J. L., Verhulst T., Verstraeten K., Hall B. M. and Sasser A. K. (20160219). Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. : Breast cancer (Dove Medical Press).

MLA

Casneuf Tineke, Axel Amy E, King Peter, Alvarez John D, Werbeck Jillian L, Verhulst Tinne, Verstraeten Karin, Hall Brett M and Sasser A Kate. Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. : Breast cancer (Dove Medical Press). 20160219.